chlormethine
Commercial- Indications
- Oncology
Company intelligence / Profile preview
Juniper Biologics commercializes and develops novel therapies with a focus on oncology, rare diseases, gene/cell therapies, and advanced diagnostics. It has exclusive regional rights to several established pharmaceutical products through licensing deals with companies like Helsinn Healthcare SA. The company also distributes advanced molecular profiling technologies from Caris Life Sciences in Asia/Middle East/Africa. Its pipeline includes both marketed drugs and clinical-stage assets such as cell-mediated gene therapy for knee osteoarthritis. It has received multiple industry awards recognizing its innovation in R&D and commercialization.
3 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Juniper Biologics.